# RNA integrity and assay suitability

Source: https://onco.cc/terms/rna-integrity/  
OnCo record `rna-integrity` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

RNA quality measurements describe the condition of extracted RNA. Their usefulness depends on the measurement workflow the material will enter.

## Summary

The original RNA Integrity Number method summarized electrophoretic features to standardize quality assessment. DV200 describes the proportion of RNA fragments longer than 200 nucleotides. Comparisons of fixed and frozen tissue found that fragment-distribution measures and functional amplification assays could be more informative for particular workflows. The NCI preanalytical-variables study likewise found method-dependent sensitivity to handling effects. An integrity score is therefore not a universal pass or fail rule for every RNA assay; input, preparation and intended measurement still matter.

## Fields

- Kind: Term
- Last checked: 2026-11-10
- Also known as: RNA integrity number; RIN score; DV200 RNA quality

## Notes

- RNA integrity concerns molecular condition and fragment distribution, while yield measures recovered quantity. RNases, handling, fixation chemistry and storage can affect recovered molecules. An electropherogram separates size-associated signal. Integrity does not measure malignant-cell share, viability, protein abundance or transcript function.
- Schroeder developed RIN from multiple electropherogram features using a trained statistical model. Its 1 to 10 scale runs from degraded to more intact RNA and is not a percentage. DV200 describes measured fragments longer than 200 nucleotides; it does not certify every transcript. In a fictional area illustration, 6 of 10 selected signal-area units above 200 nucleotides give 60%. This is not a computation of RIN or an assay acceptance rule.
- Illumina describes DV200 for its RNA enrichment workflows and cautions that RIN can be insensitive in degraded FFPE samples. The older fixed ovarian-tumour study assessed shorter-fragment metrics and library performance because RIN and DV200 did not capture all limitations. Those findings and kit cutoffs must stay with their protocols, rather than becoming universal input rules.
- Fictional fixed RNA has low RIN but is accepted for a validated short-target expression assay and rejected for a full-length transcript workflow. These decisions can be consistent because the questions need different evidence. Passing input QC does not establish library complexity or gene recovery; a weak negative can reflect failed recovery rather than biological absence. Gene counts do not prove full-length or splice structure.
- RNA quality assessment uses an aliquot of an extract, which itself consumed specimen material. Examine the fragment-size distribution and method-specific quality summary, then check downstream recovery. Report RIN on its 1 to 10 scale, DV200 as a percentage, RNA quantity in nanograms and relevant library or recovery metrics. Acceptance depends on preservation, input amount and the intended assay; there is no universal RIN or DV200 pass cutoff. Poor extraction, degradation, chemical damage, contaminants, insufficient quantity or an uninterpretable trace can limit testing. Integrity does not measure tumour purity, cell viability, protein abundance or transcript function, and a research suitability metric is not a diagnostic result.

## Sources

- The RIN: an RNA integrity number for assigning integrity values to RNA measurements.: https://doi.org/10.1186/1471-2199-7-3
- Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples.: https://doi.org/10.1038/s41598-018-24781-6
- The Biospecimen Preanalytical Variables Program: A Multiassay Comparison of Effects of Delay to Fixation and Fixation Duration on Nucleic Acid Quality.: https://doi.org/10.5858/arpa.2018-0172-oa
- The RIN: an RNA integrity number for assigning integrity values to RNA measurements.: https://pubmed.ncbi.nlm.nih.gov/16448564/
- Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers.: https://pubmed.ncbi.nlm.nih.gov/22034635/
- Robustness of RNA sequencing on older formalin-fixed paraffin-embedded tissue from high-grade ovarian serous adenocarcinomas.: https://pubmed.ncbi.nlm.nih.gov/31059554/
- Technical Note: RNA Sequencing: https://support.illumina.com/content/dam/illumina-marketing/documents/products/technotes/evaluating-rna-quality-from-ffpe-samples-technical-note-470-2014-001.pdf
- NCI Biospecimen Evidence-Based Practices: snap-freezing of post-surgical tissue: https://dctd.cancer.gov/data-tools-biospecimens/snap-freeze-bebp.pdf

## Connected records

- terms: [Immune measurements and product evidence](https://onco.cc/terms/immune-product-evidence/), [Tissue preparation and assay suitability](https://onco.cc/terms/tissue-preparation-assay-fit/)
- technologies: [Pre-analytics: blood-collection tubes and tissue fixation](https://onco.cc/technologies/preanalytics-sample-stabilisation/), [RNA sequencing & expression profiling](https://onco.cc/technologies/rna-seq/)

---
JSON: https://onco.cc/api/v1/entities/rna-integrity.json